CATACCHIO, GIACOMO
CATACCHIO, GIACOMO
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis
2021-01-01 Favoino, E.; Urso, L.; Serafino, A.; Misceo, F.; Catacchio, G.; Prete, M.; Perosa, F.
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients
2022-01-01 Favoino, Elvira; Catacchio, Giacomo; Mininni, Alessandra; Ruscitti, Piero; Riccieri, Valeria; Liakouli, Vasiliki; Corrado, Addolorata; Navarini, Luca; Ciccia, Francesco; Cipriani, Paola; Cantatore, Francesco Paolo; Valesini, Guido; Giacomelli, Roberto; Perosa, Federico
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial?
2020-01-01 Prete, Marcella; Favoino, Elvira; Catacchio, Giacomo; Racanelli, Vito; Perosa, Federico
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment
2020-01-01 Prete, M.; Favoino, E.; Catacchio, G.; Racanelli, V.; Perosa, F.
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
2021-01-01 Favoino, Elvira; Prete, Marcella; Catacchio, Giacomo; Ruscitti, Piero; Navarini, Luca; Giacomelli, Roberto; Perosa, Federico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis | 1-gen-2021 | Favoino, E.; Urso, L.; Serafino, A.; Misceo, F.; Catacchio, G.; Prete, M.; Perosa, F. | |
| Novel biomarker for pulmonary vascular disease in systemic sclerosis patients | 1-gen-2022 | Favoino, Elvira; Catacchio, Giacomo; Mininni, Alessandra; Ruscitti, Piero; Riccieri, Valeria; Liakouli, Vasiliki; Corrado, Addolorata; Navarini, Luca; Ciccia, Francesco; Cipriani, Paola; Cantatore, Francesco Paolo; Valesini, Guido; Giacomelli, Roberto; Perosa, Federico | |
| SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? | 1-gen-2020 | Prete, Marcella; Favoino, Elvira; Catacchio, Giacomo; Racanelli, Vito; Perosa, Federico | |
| Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment | 1-gen-2020 | Prete, M.; Favoino, E.; Catacchio, G.; Racanelli, V.; Perosa, F. | |
| Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? | 1-gen-2021 | Favoino, Elvira; Prete, Marcella; Catacchio, Giacomo; Ruscitti, Piero; Navarini, Luca; Giacomelli, Roberto; Perosa, Federico |